These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 1708914

  • 41. Comparative evaluation of antiherpetic drugs in animal experiments.
    Streissle G.
    Adv Ophthalmol; 1979; 38():43-8. PubMed ID: 525527
    [No Abstract] [Full Text] [Related]

  • 42. [The treatment of viral hepatitis].
    Dhumeaux D.
    Servir; 1991; 39(6):304-5. PubMed ID: 1723221
    [No Abstract] [Full Text] [Related]

  • 43. Optimizing PEG-interferon and ribavirin combination therapy for patients infected with HCV-2 or HCV-3: is the puzzle completed?
    Alberti A.
    J Hepatol; 2004 Jun; 40(6):1032-5. PubMed ID: 15158348
    [No Abstract] [Full Text] [Related]

  • 44. [Treatment of chronic hepatitis C: still many problems pending].
    Bruguera M.
    Gastroenterol Hepatol; 1997 Jan; 20(1):31-42. PubMed ID: 9072195
    [No Abstract] [Full Text] [Related]

  • 45. [Therapy of chronic hepatitis (author's transl)].
    Arnold W, Meyer zum Büschenfelde KH.
    Leber Magen Darm; 1981 Apr; 11(2):73-80. PubMed ID: 6164895
    [Abstract] [Full Text] [Related]

  • 46. [New developments in therapy and prophylaxis of viral hepatitis (author's transl)].
    Thaler H.
    Acta Med Austriaca; 1981 Apr; 7(2):43-8. PubMed ID: 6163300
    [Abstract] [Full Text] [Related]

  • 47. [Treatment problems in chronic hepatitis].
    Chernev K.
    Vutr Boles; 1982 Apr; 21(1):6-12. PubMed ID: 6178223
    [No Abstract] [Full Text] [Related]

  • 48. Herpes simplex type 1 defective interfering particles do not affect the antiviral activity of acyclovir, foscarnet and adenine arabinoside.
    Harmenberg JG, Svensson LT.
    Acta Virol; 1988 Mar; 32(2):153-5. PubMed ID: 2899962
    [Abstract] [Full Text] [Related]

  • 49. Levamisole treatment of acute viral hepatitis and HBsAG-positive chronic active hepatitis.
    Pár A, Barna K, Bajtai G, Hollós I, Ambrus M, Kovács M, Jávor T.
    Acta Med Acad Sci Hung; 1980 Mar; 37(3):269-81. PubMed ID: 7457030
    [Abstract] [Full Text] [Related]

  • 50. [Active chronic hepatitis caused by the B virus (ACH-B). Recent pathogenetic acquisitions and elements of serological, clinical and histopathological diagnosis].
    Romeo F, Spina A, Cannaò G.
    Recenti Prog Med; 1980 Dec; 69(6):577-643. PubMed ID: 6166032
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. CMV retinitis and the use of FK 506.
    Paul AA, Leeper HF, Friberg TR.
    Transplant Proc; 1991 Dec; 23(6):3042-3. PubMed ID: 1721354
    [No Abstract] [Full Text] [Related]

  • 53. Treatment of chronic hepatitis.
    Sherlock S.
    Ann Acad Med Singap; 1980 Apr; 9(2):185-7. PubMed ID: 6158903
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Immunological aspects of antiviral therapy.
    Peters M.
    Springer Semin Immunopathol; 1990 Apr; 12(1):47-56. PubMed ID: 1695028
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Interferon in chronic hepatitis B infection.
    Merigan TC, Robinson WS, Gregory PB.
    Lancet; 1980 Feb 23; 1(8165):422-3. PubMed ID: 6101871
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.